Top Markets
Coin of the day
Ultimovacs ASA Ultimovacs ASA

Ultimovacs ASA

ULTI
Rank in Stocks #34179
Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established... Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.
Share Price
$0.17687105
Last synced: 2025-04-01
Market Cap
$6.08M
Change (1 day)
-89.96%
Change (1 year)
0.00%
Country
NO
Trade Ultimovacs ASA (ULTI)

Category

P/B ratio for Ultimovacs ASA (ULTI)
P/B ratio as of 2026 TTM: 0
According to Ultimovacs ASA latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Ultimovacs ASA from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE